Overview

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy

Status:
Completed
Trial end date:
2019-04-18
Target enrollment:
Participant gender:
Summary
This is a Phase 3, open label, long term follow-up (LTFU), multicenter, noncomparative, and single arm study of brivaracetam (BRV).
Phase:
Phase 3
Details
Lead Sponsor:
UCB BIOSCIENCES, Inc.
Treatments:
Brivaracetam